Explore Next-Generation Pathogen Inactivation for Vaccine Development
World Vaccine Congress 2026
Join KyooBe at Booth 535 and discover how KyooBe Tech’s eFIT technology can support vaccine manufacturing
through rapid, radiation-based pathogen inactivation.
Visit KyooBe at Booth 535
This October, the global vaccine community comes together in Amsterdam at World Vaccine Congress Europe.
Meet our team to discuss your pathogen inactivation challenges and explore whether eFIT is the right solution for your application.
Topics we’ll be happy to discuss:
- How eFIT works, including a live demo of our eFIT irradiation cassette
- The potential of Low-Energy Electron Irradiation (LEEI) for pathogen inactivation
- Applications in vaccine development and manufacturing
- eFIT Feasibility Studies for application-specific assessment
Book your eFIT Feasibility Study at World Vaccine Congress
An eFIT Feasibility Study provides a fast, application-specific assessment using your biological material, generating valuable insights into pathogen inactivation performance, product integrity, and the suitability of eFIT for your specific application.
Discuss your project with our experts and discover how a feasibility study can support your development.
Meet our Experts
Meet KyooBe at World Vaccine Congress in Amsterdam
Schedule a meeting in advance or stop by our booth to learn how eFIT technology can support your pathogen inactivation strategy.
Lena Schober
Director Business Development & Application
